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Abstract: Collagen-based constructs have emerged in recent years as ideal candidates for tissue
engineering implants. For many biomedical applications, collagen is crosslinked in order to improve
the strength, stiffness and stability of the construct. However, the crosslinking process may also result
in unintended changes to cell viability, adhesion or proliferation on the treated structures. This review
provides a brief overview of some of both the most commonly used and novel crosslinkers used with
collagen, and suggests a framework by which crosslinking methods can be compared and selected
for a given tissue engineering application.
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1. Introduction
In recent years, there has been considerable interest in the use of collagen as a base biomaterial
for tissue engineering applications. Collagen is ubiquitous even in tissues that are biologically and
structurally distinct. The natural stratification and localisation of cells achieved within the body
is guided by biochemical and biomechanical cues presented by the extracellular matrix and the
physiological conditions at the site of the tissue. While several of these cues can be tailored through
additive manufacturing in a scaffold, some alterations can arise naturally from the choices made during
the core synthesis of a scaffold. As a result, the changes to structure and properties imparted across the
length scales by the underlying fabrication processes cannot be overlooked. In particular, the process
of crosslinking not only improves the mechanical properties of a collagen scaffold but also results in
further modifications to the molecular structure of collagen. In this review, we present an overview
of the collagen crosslinking process, with the view to explore the influence of current methods and
reagents on both the mechanical and biological properties of the resulting crosslinked constructs.
2. Considerations in Selecting a Chemical Crosslinker
The fundamental aim of chemical crosslinking is to improve the mechanical properties and
stability of the final processed collagen product. However, the selection of an appropriate crosslinker
may depend on several factors. Since collagen is often used in biomedical applications to replicate
the biochemical environment experienced in vivo, amine-based crosslinkers [1–5] are often chosen
in order to mimic the lysine-based crosslinks which are naturally present in collagen [6]. The choice
and mechanism of crosslinking can also inadvertently modify other structural attributes and the
corresponding biological response. For instance, chemical crosslinkers may be broadly classified by
their potential to incorporate the crosslinker directly into the protein. This results in the ‘zero length’
crosslinkers, which do not remain a part of the protein structure post-crosslinking, or ‘non-zero length’
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crosslinkers, where some or all of the crosslinker is incorporated. While zero-length crosslinkers may
modify the local chemical structure, resulting in non-native like cellular interactions [7], there is also
some concern with the potential of non-zero length crosslinked collagen films to release cytotoxic
products when metabolised [8].
This review is centred around an assessment of some of the most common crosslinking agents
which are predominantly amine-based, and cover a range of zero length as well as non-zero length
crosslinkers. These include traditional crosslinkers such as glutaraldehyde (GTA), a non-zero length
crosslinker, and EDC-NHS, ultraviolet radiation (UV), dehydrothermal treatment (DHT), which are
zero-length crosslinkers. Novel and emerging crosslinking methods include the use of genipin as a
non-zero length crosslinker, as well as riboflavin and tissue transglutaminase 2 (TG2) as zero-length
crosslinkers. This review also focuses on the effect of crosslinking on Type I collagen, and uses
a standardised w/w% notation to indicate the mass of the crosslinker used per gram of collagen.
Following an assessment of these crosslinkers on various physical, chemical and biological properties
in collagen-based constructs, an appropriate crosslinker can be therefore be chosen on the basis of the
properties demanded by the application of interest.
3. An Overview of Selected Chemical Crosslinkers
3.1. Glutaraldehyde
GTA is a chemical crosslinker widely studied in tissue engineering owing to its excellent ability
to increase the elastic modulus of scaffolds [9]. GTA produces imide crosslinked collagen fibres,
as illustrated by the crosslinking mechanism in Figure 1. As seen from the reaction mechanism with
collagen, GTA is not a zero-length crosslinker and the resulting structure includes parts of the linker
molecule in the final crosslinked collagen.
Figure 1. Crosslinking mechanism of glutaraldehyde (GTA). Illustrations redrawn from proposed
mechanisms by Olde Damink et al. [1].
Glutaraldehyde has also successfully been shown to achieve an exceptionally high degree of
crosslinking, with complete (amine-based) crosslinking achieved above 0.12 w/w% on porcine dermal
telocollagen-poor collagen gels [10]. This is, however, accompanied by the caveat that crosslinks can
be made both within and across collagen fibrils, and that an increase in crosslink density does not
always correspond to a similar increase in mechanical properties [1]
One of the earliest systematic studies of the effect of GTA on the mechanical properties of treated
collagen was performed by Olde Damink et al. in 1995. GTA crosslinking of dermal ovine collagen
was shown to increase the low strain modulus upon crosslinking from 1.7 to 3.5 MPa at 0.5 w/w%,
although the high-strain modulus was noted to decrease slightly from 32.7 to 21.0 MPa with increasing
crosslinking concentration [1].
Furthermore, Chen et al. found that cell seeding and proliferation (by preventing the cell-mediated
contraction of a Type I rat tail atelocollagen-derived scaffold) was improved with GTA crosslinking,
while differentiation was noted to be significantly hindered in comparison with the non-crosslinked
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scaffolds [11]. The by-products of degradation in later metabolic pathways were also observed to
result in the cytotoxicity observed, although there is no evidence of carcinogenicity or mutagenicity
with the use of GTA [8].
3.2. EDC-NHS
EDC(1-ethyl-3-(3-dimethylaminopropyl) carbodiimide)-NHS(N-hydroxysuccinimide) is a
common collagen crosslinker offering a non-cytotoxic, zero-length crosslinking alternative to GTA.
The zero-length crosslinking results in access being limited to ‘neighbouring’ free amines [12],
following a reaction mechanism, as illustrated in Figure 2. These crosslinks occur between glutamates
and arginines/lysines, in either case affecting the GXOGER sequence that is recognised by the integrins
which mediate cell binding on collagen, where the amino acid X is most commonly phenylalanine (F).
Figure 2. Crosslinking mechanism of EDC-NHS. Illustration redrawn from proposed mechanisms by
Haugh et al. [13] Image modified from Nair et al. [14] licensed under CC-BY 4.0.
With EDC-NHS, the standard ‘100% concentration’ [2,15] is often defined as a precise molar ratio
of 5:2:1 EDC:NHS:COO−, where COO− refers to the carboxylate groups in the protein. Assuming a
ratio of 120 COO− for a collagen chain with a molecular weight of 100,000 [2], this molar ratio can be
re-written as a mass ratio corresponding to 1.150:0.276:1 EDC:NHS:Collagen, i.e., 1.150 w/w% EDC
and 0.276 w/w% NHS. A scaling from this standard concentration would then be represented by the
proportion of EDC and NHS to collagen. For instance, a 50% standard concentration would refer to a
0.575:0.138:1 mass ratio of EDC:NHS:COO−. For consistency, concentrations will be expressed in terms
of this industry standard. Where modifications are made to this standardised ratio, concentrations
will be reported in terms of the mass ratio (w/w%) so that comparisons can be made with other
chemical crosslinkers.
EDC-NHS crosslinking allows for a lower crosslink density than traditional crosslinkers such as
GTA, but provides a more hydrophilic surface, that has been shown to be beneficial for fibronectin
activity and a greater degree of swelling compared with traditional crosslinkers on Type I bovine
dermal swollen gel-derived collagen fibres (with chondroitin-6-sulfate additives) [12]. Furthermore,
EDC-NHS was also shown to induce the self-assembly of collagen bundles roughly 300-nm in width
with both acid-soluble and insoluble Type I bovine dermal collagen, suggesting the possibility of
both intra-fibril and inter-fibril binding, in spite of being a zero-length crosslinker. The insoluble
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collagen fragments revealed an enhancement and localisation of the piezoelectric response along these
self-assembled fibre bundles [16].
Historically, up to 200% (i.e., 10:4:1 EDC:NHS:COO−) of the standard condition has been used
in crosslinking collagen, but extensive research on EDC-NHS composition and its effect on both cell
migration and mechanics [13,15,17–19] suggest that much lower concentrations (10–100%) can retain
the improvements in the mechanical properties imparted by crosslinking. For instance, Ahmad et al.
investigated extruded collagen fibres (Type I bovine dermal acid-swollen gel collagen) which were
crosslinked at three different EDC-NHS concentrations (0.02 w/w EDC%—0.006 w/w% NHS, 0.002 w/w
EDC%—0.0006 w/w% NHS and 0.0002 w/w EDC%—0.00006 w/w% NHS) [18]. Of the three mechanical
properties of interest to their study, the ultimate tensile strengths, in particular, were observed to be
unaffected by the crosslinking concentrations used.
In the same study by Ahmad et al., human tenocytes derived from anterior cruciate ligaments
and seeded on these extruded collagen fibres demonstrated lower levels of attachment on fibres that
were heavily crosslinked after 24 h [18]. Analysis of the cell population after three weeks of seeding
also indicated lower levels of tenocyte proliferation on the heavily crosslinked fibres. From these
results, the authors speculated that the crosslinking conditions could be reduced by nearly two orders
of magnitude without affecting the tensile properties desired for tendon repair [18].
Furthermore, a recent patent by Geistlich Pharma AG also supported the used of a low-EDC-NHS
crosslinking concentration. Their collagen-based sponges (created from a wide variety of mammalian
sources) for tissue regeneration in oral cavities have been shown to allow complete regeneration of
gingival cells whilst withstanding the forces accompanied by the movement of the jaw and tongue
during mastication and speech. This collagen-based sponge was crosslinked using 0.3 g of EDC per
gram of collagen [20], which can be expressed as 26% of the standard crosslinking concentration.
Similar observations of reduced cellular attachment with EDC-NHS crosslinking were reported
with C2C12 mouse cardiomyocytes by Grover et al., as well as platelet and HT1080 fibrosarcomas
by Davidenko et al., on crosslinked collagen films (Type I microfibrillar bovine dermal and Achilles
tendon) but not on crosslinked gelatin films (bovine dermal) [15,17]. The hypothesis emerging from
these studies related the observed reduction in the cellular attachment to the ablation of the GXOGER
motifs in collagen through the carbodiimide crosslinking process. Due to the availability of RGD
motifs for cell binding in gelatin (which is cryptic in collagen), similar decreases in cell binding are not
observed with the crosslinking of gelatin.
Bax et al. further investigated the effect of EDC-NHS crosslinking on integrin binding with the
aim to provide a mechanistic understanding of the manner in which the crosslinkers modify the
collagen backbone to produce the observed reduction in cell attachment [7]. Bax et al. isolated the
biochemical receptors which participate in binding with the crosslinked Type I bovine Achilles tendon
collagen substrates by characterising the attachment of two integrin I domains (α1 and α2) and four
different model cell lines expressing different collagen-binding integrins: platelets, HT1080 human
fibrosarcomas, Rugli rat glioma cells and C2C12 mouse fibroblasts with transfected integrin I domains.
Through isolated integrin domain binding and cellular attachment experiments to collagen,
the authors were able to conclude that four collagen integrins were affected by the EDC-NHS
crosslinking: α1β1, α2β1, α10β1, and α11β1. As a result, the mechanism illustrated in Figure 3 was
proposed to described the loss of integrin-binding due to the involvement of glutamic acids in the
crosslinks formed by EDC-NHS.
Since the binding of the I-domain in an integrin is dependent on its coordination with a divalent
cation supported by MIDAS (metal ion dependent adhesion site) motifs, the loss of glutamates during
EDC-NHS crosslinking is suggested to ablate the GXOGER motifs on collagen. At high values of
EDC-NHS crosslinking (≥10%), the extent of GXOGER ablation caused by the carbodiimide has been
suggested to promote non-native cellular interactions with the substrate [7].
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Figure 3. Mechanism of integrin adhesion loss through EDC-NHS crosslinking. The I-domains of
integrins coordinate to collagen through a divalent cation (Mg2+), which is supported by the glutamic
acid residue in the GXOGER MIDAS motif (GFOGER variant illustrated here). The formation of the
peptide bond between glutamic acids (E) and lysines (K) is suggested to be the origin of the observed
loss of integrin-specific attachment to EDC-NHS crosslinked collagen. Adapted from Bax et al. [7].
3.3. Dehydrothermal Treatment
DHT exploits LeChatelier’s principle of driving a reaction forward by removing the by-product
of crosslinking, water, through the application of heat and vacuum, as seen in Figure 4.
Madaghiele et al. investigated the effect of DHT held at a range of temperatures (110, 120, 140, 160, 160,
180 ◦C) at 30–50 Torr for 24 h after ramping for an hour on Type I bovine dermal collagen scaffolds.
The compressive elastic modulus of DHT-treated films was shown to increase with the applied DHT
temperature, in line with the crosslink density of the films [21]. The treated collagen films were also
susceptible to denaturing during the process, with significant denaturing (57.84%), crumpling and
embrittlement at higher temperatures (180 ◦C) [21]. The crosslink density of DHT-treated collagen
extracted from steer hide was found to increase with temperature from 105 to 125 ◦C, but not with
time after 3 days [22]. Although some denaturing of collagen is proposed to increase the crosslinking
density by allowing access to hidden groups, beyond 145 ◦C or 5 days, significant denaturing and
reduced mechanical properties were observed [22].
Soller et al. conducted an in vivo assessment of DHT-treated Type I microfibrillar
collagen–chondrotin-6-sulfate scaffolds in transected rat peripheral nerves [23]. The conditions of study
included treatments at 90 ◦C for both 24 and 48 h, and 120 ◦C for 48 h under a vacuum of 50 mTorr.
In this study, nerve regeneration was supported more successfully by the treatments at higher times
and temperatures, providing an optimal degradation time-frame to match the rate of regeneration
of the tissue. Additionally, an investigation of the in vitro cell response of DHT-treated Type I
collagen–choindroitin-6-sulfate collagen scaffolds was conducted by Haugh et al. using MC3T3-E1
mouse preosteoblasts at higher temperatures. These scaffolds were treated at four temperatures (105,
120, 150 and 180 ◦C) under a vacuum of 37.5 Torr, although the duration was not specified. DHT-treated
scaffolds displayed an extreme seeding and proliferation of the preosteoblasts in comparison with
EDC-NHS or GTA-crosslinked scaffolds in the same study, particularly at the higher temperature of
150 ◦C [13]. While the results of an in vivo and in vitro test cannot be directly compared, it is likely that
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the use of DHT-treatment to elicit high cellular activity may be limited to lower treatment temperatures
where the risk of denaturing is also low.
Figure 4. Dehydrothermal mechanism of crosslinking. Illustration redrawn from mechanisms by
Haugh et al. [13].
3.4. Ultraviolet Radiation
The use of UV to crosslink collagen is a relatively novel technique that relies on the formation of
highly reactive radicals to facilitate the formation of crosslinks within the structure. There is no strict
chemical mechanism due to the non-specificity of radical based reactions, but amino acid analyses
give evidence of crosslinks through aromatic residues, like phenylalanine and tyrosine [24,25] that are
able to stabilise the radicals within their de-localised pi-systems.
An investigation by Sionkowska on UV-irradiated films made from acid-soluble rat tail tendon
collagen revealed a reduction in thermal stability and the creation of surface flaws such as wrinkles
and micro-cracks after UV crosslinking at λ = 254 nm, 0.196 J cm−2min−1, for 2, 4 and 8 h [26].
The UV radiation applied was suggested to disrupt the hydrogen bonds within and across the collagen
in these samples, thus initiating the release of water and the production of collagen fragments [26].
This fragmentation of collagen has been shown to be limited through the use of glucose by inhibiting the
unwinding of the triple helices in bovine insoluble dermal and Achilles tendon collagen constructs [24,27].
Davidenko et al. conducted an assessment of the physical properties of UV-irradiated collagen
films and scaffolds both with and without the presence of glucose. Type I bovine dermal scaffolds and
bovine Achilles tendon collagen scaffolds and films were produced, and subsequently treated at a
range of UV conditions (λ = 254 nm for 30 min). Scaffolds were irradiated at a range of intensities
(0.06–0.96 J cm−2), whereas films were only irradiated at either 0.42 or 0.96 J cm−2. The crosslink
densities achieved were very low despite long exposure times, giving rise to a maximum Young’s
modulus under 2 kPa for tendon collagen treated with glucose, and 0.5 kPa without any additives [24].
Moreover, the influence of UV-crosslinking on degradation stability in water was found to be dependent
on the collagen source. UV crosslinking improved the stability of tendon collagen, displaying no
dependence on irradiation intensities whereas the stability of dermal collagen was improved at the
lowest intensity and decreased at higher values. This was reconciled by the competing effects of
collagen crosslinking and collagen denaturation that occur during UV-treatment [24].
In the same study, the authors also investigated the in vitro cellular integrin-mediated cellular
response to UV crosslinking. α2β1 integrin mediated binding of HT1080s and platelets, as well as
spreading and proliferation of HT1080s was found to be unaffected by UV crosslinking, suggesting
that the GXOGER sequences were unaffected by the UV-treatment [24]. Building upon these results,
the synergistic effects of UV crosslinking (λ = 254 nm, 0.42 or 0.96 J cm−2 for 30 min) and EDC-NHS
crosslinking (0–200% of the standard condition as defined in Section 3.2) was investigated by
Bax et al. on Type I insoluble bovine Achilles tendon collagen. UV-irradiation was found to inhibit
the adhesion of α2 I-domains above the expected effect from EDC-NHS alone, with a EDC-NHS
concentration-dependent inhibition of HT1080 cell adhesion and cell coverage). This was proposed
to occur due to the involvement of phenylalanine (F) in UV crosslinking, resulting in the loss of
GFOGER crosslinking motifs, the most strongly binding of the GXOGER motifs. As a result, binding is
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compensated through the GLOGER motifs, where L represents Leucine, which is compensatory for
α1-I domain binding, but a weak association for α2-I domains [28].
3.5. Genipin
Genipin, a compound extracted from the fruits of the Gardenia jasminoides Ellis, emerged as an
alternative crosslinker for crosslinking biomaterials in light of the cytotoxicity of crosslinkers such as
glutaraldehyde and formaldehyde [29]. Due to the established food safety of genipin, the crosslinking
method has been suggested for use in collagen, gelatin and chitosan-based scaffolds and drug-delivery
systems [29]. Genipin has been used as a crosslinker in chitosan-based scaffolds and is proposed to
follow the same two-step mechanistic pathway in both chitosan and collagen. One of the crosslinking
steps has been reported in earlier studies to involve a secondary amide linkage of a free amine to the
genipin via an SN2 nucleophilic substitution [30,31], and, more recently, the second crosslink has been
described to form via two further pathways to complete the crosslinking to collagen, through either two
imide crosslinks, or two amide crosslinks, as shown in Figure 5 [31]. Genipin crosslinks gelatin through
lysine and arginine groups and is expected to follow a similar mechanistic pathway in collagen [32].
The crosslinks formed with genipin offer collagen scaffolds increased elastic modulus by nearly an
order of magnitude, as shown by Zhang et al. The authors found that treating Type I rat tail tendon
derived collagen scaffolds of 92% porosity was most effective at high crosslinking concentrations
(0.7812 w/w%) and temperatures (20–37 ◦C), producing compressive elastic modulus of 30 kPa when
compared against a non-crosslinked control at 5 kPa [33].
Figure 5. Crosslinking mechanism of genipin. First mechanism proposed in Butler et al. [30] Second
proposed in Tambe et al. [31]. Image modified from Nair et al. [14] licensed under CC-BY 4.0.
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There is some evidence to support the cytotoxicity of genipin at very large concentrations (>5 mM),
according to a study by Sundararaghavan et al. which evaluated the effect of genipin-crosslinked
Type I collagen gels without washing post-treatment with genipin [32]. However, the effect on washed
scaffolds was found to be minimal. In addition, following neurocompatibility and long-term large
animal studies, Singh et al. investigated the use of genipin which was directly injected into the spine
of five patients to alleviate their chronic lower back pain by improving the mechanical properties of
the annulus [34]. At the end of their six month study, the authors observed an improvement in the
flexion-extension instability reduction and patient satisfaction in 75% of their patients. Patients only
experienced temporary central pain associated with the procedure, and the leg pain experienced by a
patient was treated and successfully resolved by the ninth week of the experiment, supporting the
safety of genipin for use in vivo.
Furthermore, an investigation of the mechanical properties of genipin by Nair et al. using Type I
bovine dermal insoluble collagen, revealed that genipin at the highest crosslinking concentrations
(1.5624 w/w % at room temperature) can act as an alternative for the intermediate crosslinking
conditions of EDC-NHS, improving both the Young’s modulus and the stress to failure [14].
Integrin-specific binding was also observed to be unaffected by the genipin crosslinking, resulting in
high human dermal fibroblast proliferation rates and low cellular toxicity [14].
3.6. Riboflavin
Riboflavin, or vitamin B2, has also arisen as a biocompatible means to achieve command-set
crosslinking of collagen constructs with blue light. Riboflavin crosslinking of collagen is of particular
interest due to the short processing times (15 min) needed to observe significant improvements in
mechanical properties (2.5-fold increase in elastic modulus) [35]. Barrett et al. established that riboflavin
can create crosslinks within a collagen construct (Type I insoluble, bovine Achilles tendon membranes)
specifically through the arginine, histidine and lysine amino acids. Although the loss of arginines
can result hinder integrin-mediated adhesion, Barrett et al. hypothesised that arginines are not as
critical in stabilising a divalent cation in the GFOGER motifs as the glutamines which are lost during
EDC-NHS crossliniing [36]. This was confirmed with cell attachment assays where only the α2β1
integrin-mediated binding was affected, as evaluated with HT1080 fibrosarcomas, whereas the integrin
binding in human dermal fibroblasts expressing a range of integrins was unaffected. Unlike EDC-NHS
crosslinked films however, riboflavin-crosslinked films did not result in an increase in non-specific
binding, whilst possessing comparable ultimate tensile strengths to EDC-NHS crosslinked collagen
membranes [36]. Additionally, an investigation of plastically compressed collagen scaffolds by
Cheema et al. observed a decrease in oxygen diffusivity and in human dermal neonatal fibroblast
viability after crosslinking a compressed collagen (Type I, rat tail, single molecule) scaffold [37].
However, this cytotoxicity may arise from an interaction between the compression and crosslinking,
since greater degrees of plastic compression resulted in a more significant decrease in cell viability
(67%) than the riboflavin crosslinking process (79%).
Transglutaminase
Transglutaminases refer to a family of transferase enzymes that crosslink proteins through
the formation of a bond between an ε-amine (lysine) and γ-carboxyl in glutamines, as shown in
Figure 6. There are many types of transglutaminases, including microbial transglutaminase, factor XII,
epidermal, keratinocyte and tissue transglutaminases, which are commonly found as crosslinking
agents in skin, hair and blood clots in vivo. Of these enzymes, tissue transglutaminase 2 (TG2),
is a calcium-dependent enzyme that has shown an exceptionally high cellular response, including
an increase in the number of osteoblast adhesion after TG2-crosslinking of freeze-dried Type I
calf-skin-derived collagen scaffolds [38].
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Figure 6. Crosslinking mechanism of tissue transglutaminase. Illustration of proposed mechanisms by
Keillor et al. [39]. Image modified from Nair et al. [14] licensed under CC-BY 4.0.
Transglutaminases bind to glutamines in the polypeptide chain, activating them for further
reactions, as depicted in Figure 6 [39]. In the presence of water, this results in the conversion of the
glutamine to a glutamate residue, whereas, in the presence of a suitable amine, an amide bond is
formed at the site of the activated glutamine [39]. Thus, TG2 can either serve to act as an amide
crosslinker that does not utilise pre-existing aspartic or glutamic acids (E and D) in the formation
of crosslinks, or, conversely, could help to re-introduce glutamates (E) in the substrate, which may
increase the number of MIDAS motifs available on the substrate for integrin recognition.
In an investigation of the mechanical properties of TG2 by Nair et al., the global mechanical
properties such as tensile modulus and failure strength of TG2-treated films were lower than
non-crosslinked Type I bovine dermal insoluble collagen films, whereas the strain to failure and
plasticity was observed to increase [14]. Regardless, the human dermal fibroblasts seeded on
these substrates were well-spread and attached to the substrate, with low cytotoxicity and high
cell proliferation.
4. Summary
An ideal tissue engineering construct will possess the mechanical properties required to withstand
the global forces, and biochemical cues to promote controlled cell invasion and proliferation at the site
of injury. Due to the mechanisms employed by chemical crosslinkers, it is impossible to modify the
mechanical properties without altering the chemical structure of collagen. The biological and chemical
behaviour exhibited by crosslinked collagen is summarised in Table 1.
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Table 1. Summary of the advantages and disadvantages of current crosslinking systems used in
collagen-based constructs.
Crosslinker Advantages Disadvantages
GTA • Increased elastic modulus [1,13] • Non-zero length crosslinker [1]• Cytotoxic [8]
EDC-NHS • Increased elastic modulus [13,17]• Zero length crosslinker [2,12]
• Loss of some integrin-specific
binding [7]
UV • Integrin binding unaffected [24]• Zero length crosslinking [24,25]
• Non-specific reaction sites [24,25]
• Low crosslink densities [24]
• Collagen fragmentation [26]
• Some denaturing [26] without use
of glucose [24,27]
DHT • Integrin binding unaffected [13]• Zero length crosslinking • Denaturation of collagen [21]
Genipin
• Non-cytotoxic [34]
• Increases in elastic modulus [33]
• Mechanism should not affect
GXOGER motifs in collagen [31]
• Not a zero-length crosslinker [31]
• Imparts a blue colour [33]
Riboflavin
• Mechanism should not affect
GXOGER motifs in collagen [36]
• Comparable ultimate tensile
strength to EDC-NHS [36]
• Some, albeit limited, loss of α2β1
mediated binding
TG2 • Mechanism do not affectGXOGER motifs in collagen [39]
• Can cause morphological changes
to collagen ultrastructure [38]
• Can result in a reduction of
Young’s modulus
As the number of crosslinking methods and cell types evaluated in the literature continues
to grow, determining the ideal crosslinker choice for a given application has become a non-trivial
task. One approach to addressing these issues draws from established representations of materials
properties through Ashby Materials Selection plots. In such plots, several of the underlying interactions
are abstracted, allowing distinct classes of materials to be compared along the same property space.
An attempt to create a materials selection map is illustrated in Figure 7, representing schematic trends
for the ‘bioactivity’ (through attachment and cytotoxicity) and ‘mechanics’ based on the literature
reviewed in this chapter. Within these observations, there is significant complexity and diversity in both
mechanical properties (tensile, compressive, shear as well as strength, strain, viscoelasticity, etc.) and
biological responses (cell lines, monoculture vs. co-cultures, attachment vs. proliferation vs. migration).
As a result, this materials selection map is intentionally left without exact values since the trends were
limited to observations made in systematic and comparative studies of crosslinked collagen. Regardless,
the schematic demonstrates the potential to extract and compare multiple properties upon crosslinking,
with protocol standardisation and systematic comparisons of crosslinkers in future studies.
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Figure 7. A schematic bioactivity-mechanics materials selection map illustrating a representation of
crosslinked or treated collagen substrates in terms of two commonly desired characteristics. The origin
represents the behaviour of native uncrosslinked collagen constructs, and the behaviour from the origin
following the arrows indicate trends observed with increasing crosslinking concentration. These trends
are illustrative of the behaviours observed in studies containing systematic comparisons of collagen
crosslinkers, but do not contain exact values and scales since there is significant variability in the types
of constructs, cell lines and measurement methods used.
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In order to produce a version of Figure 7 that allows for direct comparison of crosslinkers across
a range of physiologically relevant systems, we suggest that future experimental methods should,
therefore, not only include the global data that are relevant for the application at hand, but also
a few additional key datasets. Firstly, as a method to standardise the effect of crosslinkers on a
common substrate such as collagen, the ‘degree of crosslinking’ should be included. Based on the
technique of choice, this may involve an amino acid analysis [28,36], or colorimetric amine-based
assays such as the TNBS [17,21,24] or Ninhydrin assays [14,16,33] to assess the presence of free
amines. Secondly, an evaluation of the mechanical properties should include access to the data
for the representative stress–strain curves in addition to the authors’ chosen mechanical metric of
interest. Secondly, we recommend the inclusion of two biological datasets: (1) cytotoxicity and
(2) cell adhesion molecule (CAM) attachment studies. While the complexity of a tissue cannot
be recreated by a single cell type, a high cytotoxicity for any cell line is often undesirable. Thus,
preliminary cytotoxicity studies on the cells of interest is a valuable inclusion for the purposes of
tissue engineering. Moreover, cellular attachment is a precursor to several complex cellular behaviour
including migration and proliferation. Although the cells of interest do not remain the same across
several tissue engineering applications, the cells studied often share several common characteristics,
including the presence of CAMs. By performing CAM adhesion assays in place of, or in addition
to cellular assays, a materials selection map can include the attachment properties of CAMs such as
integrins, allowing the behaviour of similar classes of cells (fibroblasts, osteoblasts and endothelial
cells) to be obtained. The reduction in cellular behaviour to the initial attachment of CAMs to the
crosslinked substrates therefore enables the separation of the biochemical and mechanical effects of
crosslinking from the cell–cell and chemokine-driven responses in more complex cellular phenomena
such as cell migration.
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